Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
Clinical trial NCT05135546 · TERMINATED
Trial details
- NCT number
- NCT05135546
- Sponsor
- Supergene, LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-27
- Primary completion
- 2023-02-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.